MaxCyte, Inc.

Are you ready? Take the leap on February 23.

We’re heading to the CRISPR Medicine Summit in Boston (23–24 Mar). Looking forward to discussions on therapeutic gene editing, delivery strategies, and clinical translation. #CRISPR #GeneEditing

We’re heading to CAR-TCR Summit Europe in London (24–26 Feb). Stop by Booth 12 to connect with Alicia Roig-Merino, Ben Cavagan, and Dawar Pasha and discuss next-gen CAR/TCR innovation and scalable manufacturing strategies. #CARTCR #CellTherapy

Electroporation is now foundational to immunotherapy—but how do you use it effectively? This eBook covers the basics of electroporation for T cell and NK cell engineering, from non-viral delivery to scalable workflows. 🔗 bit.ly/3OltYAl

From the floor at CGT Manufacturing DACH in Basel. Great discussions on scalable CGT manufacturing, plus our lineup of plushie cells & molecules!

We’ll be in Basel for CGT Manufacturing DACH 2026 (11–12 Feb). Looking forward to conversations on scalable CGT manufacturing. More info: bit.ly/4r5FoX3

One month to Festival of Biologics USA in San Diego (4–5 Mar). Looking forward to conversations across biologics and CGT! bit.ly/3I7j212

We’re serious about cell engineering — and about having fun. Team building was part of our recent General Sales Meeting, including a night at Dave & Buster’s. Congrats to the Red Team for winning the scavenger hunt—and to all for a great meeting. Energized for the year ahead!

Looking forward to CAR-TCR Summit Europe! 📍 London, UK 📅 24–26 Feb 2026 An exciting forum for next-generation CAR and TCR innovation—spanning receptor and signaling design through to scaling, automation, and point-of-care strategies. bit.ly/3XTHqdX

We’re excited for the next stop on the 2026 G-Rex® Grant Tour: Philadelphia on Feb 19. 📍 The Franklin Institute 🕚 11 AM–9 PM Stop by our table and say hello to Sarah Schuett. 👉 Register here: bit.ly/4pU6IGA

Having a great time at ISGCT 2026 in Galway. Fantastic conversations, familiar faces, new connections—and a small nod to the Emerald Isle if you look closely. Be sure to visit us at booth 18 on day 2. Sláinte! #ISGCT2026 #CellGeneTherapy

We’re excited to be going to Basel for Biologics / CGT Manufacturing DACH 2026 🇨🇭 📅 Feb 11–12 | 📍 Basel Marriott Hotel 🎯 Sponsor & exhibitor 📌 Poster: Accelerating Next-Gen Cell Therapy Manufacturing Meet Amandine Girard & Miguel Jimenez 🔗 bit.ly/4r5FoX3

One week to #ISGCT2026 in Galway. We’ll be at Booth 18—stop by to meet Ben Cavagan (BD Manager) and Linda Meggiolaro (FAS). Looking forward to connecting with the cell & gene therapy community. bit.ly/4pCyNSH

The 2026 G-Rex® Grant Tour, hosted by ScaleReady, kicks off in Houston on Jan 21. 📍 Texas Medical Center (TMC3) Meet and hear from industry, academic & patient advocacy experts in CGT. We’re excited to be there with a MaxCyte table on site. 👉 bit.ly/49gAksQ

This is what investing in your success upfront means: Working with Kamau Therapeutics, we helped optimize and qualify a scalable, closed CMC process using our ExPERT platform, supporting advancement of nula-cel into the clinic for sickle cell disease: bit.ly/3Ypho53

Two weeks until ISGCT 2026 in Galway. We’re excited to be attending and connecting with the global cell & gene therapy community around the science, technologies, and collaborations shaping what’s next. See you there! #ISGCT2026 #CellGeneTherapy

Happy New Year's 2026! We’re excited to work with you this year on continued growth and development in cell engineering and gene editing. Here we go!

Want a quick refresher on MaxCyte workflows—and more case studies like this clip? Earlier this year, we shared a quick 15-min overview of how high-efficiency electroporation supports cell engineering from discovery through manufacturing. Watch on demand: bit.ly/4p0j0wJ

Happy holidays from all of us at MaxCyte. Wishing you a wonderful season and a strong start to the new year!

Think of the Strategic Platform License as the next step to build momentum. KSQ Tx & MaxCyte worked through editing, scalability, and TIL variability challenges together—building a GMP-ready process and clearing IND for KSQ-001EX. KSQ case study → bit.ly/4pPGJBf